Structure-activity relationship studies on rhodamine B-based fluorogenic probes and their activation by anticancer...

Area of Science:

• Chemical Biology
• Medicinal Chemistry
• Cellular Imaging

Background:

• Fluorescence microscopy is key for visualizing intracellular platinum (Pt) species from anticancer drugs like cisplatin.
• A novel rhodamine-B based probe, Rho-DDTC, selectively detects Pt(II) compounds.
• Rho-DDTC differentiates Pt(II) from Pt(IV) carboxylate prodrugs, aiding study of Pt(IV) reduction post-cellular entry.

Purpose of the Study:

• To elucidate the activation mechanism of the fluorogenic probe Rho-DDTC.
• To perform a structure-activity relationship (SAR) study on Rho-DDTC analogues.
• To establish Rho-DDTC as a platform for investigating intracellular Pt species.

Main Methods:

• Synthesis and characterization of Rho-DDTC structural analogues.
• Structure-activity relationship (SAR) analysis.
• Fluorescence microscopy imaging of intracellular Pt species.

Main Results:

• Identification of key structural features governing Rho-DDTC activation by Pt(II).
• Demonstration of Rho-DDTC's selectivity for Pt(II) over Pt(IV) carboxylate complexes.
• Establishment of the probe's utility in studying platinum drug mechanisms.

Conclusions:

• Rho-DDTC activation is dependent on specific structural motifs.
• The probe enables selective imaging of intracellular Pt(II) species.
• Rho-DDTC serves as a valuable tool for investigating platinum-based anticancer drug mechanisms.